Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Mechanism
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Mechanism
Emergency use authorization Experimental Antiviral Jan/23/2023
Remdesivir
Mechanism
Approved by FDA Experimental Antiviral Jan/18/2023
Mesenchymal stem cells
Mechanism
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
IMAT-MSCs
Mechanism
Potential treatment - pre-clinical evidence Experimental Other treatment Sep/23/2022
Nirmatrelvir
Mechanism
Emergency use authorization Experimental Antiviral Jun/23/2022
Etesevimab
Mechanism
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
S309
Mechanism
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022
BNT162b2
Mechanism
Approved by FDA Experimental Vaccine Jun/22/2022
Cilgavimab
Mechanism
Emergency use authorization Experimental Antiviral Jun/18/2022
Tixagevimab
Mechanism
Emergency use authorization Experimental Antiviral Jun/18/2022
Bebtelovimab
Mechanism
Emergency use authorization Experimental Antiviral Jun/18/2022
Convalescent plasma
Mechanism
Emergency use authorization Experimental Antiviral May/16/2022
Baricitinib
Mechanism
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
P2C-1F11
Mechanism
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
hu33
Mechanism
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/25/2022
PDA@Exosome
Mechanism
Potential treatment - pre-clinical evidence Experimental Other treatment Jan/22/2022
S2K146
Mechanism
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/06/2022
mAb 222
Mechanism
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-55
Mechanism
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022